Novozymes A/S (OTCMKTS:NVZMY) Short Interest Down 20.1% in February

Novozymes A/S (OTCMKTS:NVZMY) saw a large drop in short interest in the month of February. As of February 27th, there was short interest totaling 4,463 shares, a drop of 20.1% from the February 12th total of 5,586 shares. Based on an average trading volume of 305,495 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are sold short. Approximately 0.0% of the shares of the company are sold short. Based on an average trading volume of 305,495 shares, the short-interest ratio is currently 0.0 days.

Novozymes A/S Stock Performance

Shares of Novozymes A/S stock traded down $0.02 on Friday, reaching $54.51. 215,947 shares of the stock were exchanged, compared to its average volume of 149,201. Novozymes A/S has a 1-year low of $53.50 and a 1-year high of $75.99. The company has a current ratio of 1.61, a quick ratio of 1.00 and a debt-to-equity ratio of 0.26. The business has a fifty day moving average price of $61.15 and a two-hundred day moving average price of $62.01. The firm has a market capitalization of $22.60 billion, a PE ratio of 38.94, a PEG ratio of 0.99 and a beta of 1.11.

Novozymes A/S (OTCMKTS:NVZMY) last announced its quarterly earnings data on Wednesday, February 25th. The biotechnology company reported $0.35 EPS for the quarter, missing analysts’ consensus estimates of $0.79 by ($0.44). Novozymes A/S had a net margin of 13.96% and a return on equity of 6.38%. The firm had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.22 billion. As a group, research analysts anticipate that Novozymes A/S will post 1.82 earnings per share for the current fiscal year.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).